Computer Aided Drug Discovery (CADD) Market – Global Analysis & Forecast, 2019 – 2030
Report ID : 233 | Region : Global
Computer aided drug discovery refers to computational methods and resources that are used to facilitate the design & discovery of new therapeutic solutions. The technique of designing a new drug with the help of bioinformatics have opened new avenues in drug research & development processes. The utilization of computational methods in research and drug discovery offers benefits such as the delivery of a new drug more accurately & cost-effectively. CADD tools can also be used to predict the effectiveness and possible side-effects of new drugs. They further assist in improving the bioavailability of possible drug molecules. For instance, in a CADD study, it was established that by introducing a triphenylphosphine group into the base molecule, pyridazinone, it was possible to obtain inhibitors for proteasome.
The high time consumption at early stages of clinical research, the high risk of failure and the high costs involved in traditional drug discovery processes will drive computer aided drug market growth in the coming years.
Some of the prominent players in the market include Albany Molecular Research Inc., Aris Pharmaceuticals,Inc., Aragen Bioscience, AstraZeneca, BOC Sciences Aaranya, and Evotec A.G., among others.
To gather deep-rooted insights with respect to market dynamics, competitive landscape and to unlock the market potential of Computer Aided Drug Discovery, subscribe to the report by clicking and filling up the ‘Pre-book’ section.